Drug intelligence / Profile preview

Kasofit Q-10

Development stage
Unknown
Lead developer
Kaiser Drugs
Modality
Small Molecules
Administration
Oral
01

Overview

Kasofit Q-10 is an oral dietary supplement developed and marketed by Kaiser Drugs Private Limited, an Indian pharmaceutical distributor. The product is a combination of L-carnitine and Coenzyme Q10 (CoQ10), formulated as tablets. Coenzyme Q10 serves as a vital electron carrier in the mitochondrial respiratory chain and acts as a potent lipid-soluble antioxidant, protecting cells from oxidative stress. L-carnitine is an amino acid derivative essential for the transport of long-chain fatty acids into the mitochondrial matrix for energy production via beta-oxidation. Together, these ingredients are intended to provide general nutritional support, enhance mitochondrial health, and provide antioxidant protection.

Brand names
Kasofit Q-10
Other names
Kasofit Q10
02

Targets

ETF (Electron transfer flavoprotein)SDH (Mitochondrial electron transport chain complex II)bc1 complex (Cytochrome bc1 complex (plasmodium))ND1 (Mitochondrial electron transport chain complex I)SLC7A1 (Cationic amino acid transporter 1)

Beyond the preview

Go deeper on Kasofit Q-10.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kasofit Q-10.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call